Key facts
- It has raised $1.6M across 1 recorded rounds; the latest was Seed Round ($1.6M) in Jul 2025.
- Aethl Bio has filed 1 Form D with the SEC, most recently Apr 2026 ($1.6M sold to 8 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·Watchlist + deal alerts for Aethl Bio
Funding rounds
1 roundsAbout Aethl Bio
Operator of a biotechnology company intended to pioneer new therapeutic platforms that fundamentally change how the body repairs itself. The company is exploring the elemental drivers of cellular recovery to develop solutions engineered to accelerate the healing needed most.
- Sector
- Healthcare
- HQ
- Pittsburgh, PA, United States
- Founded
- 2025
- Employees
- 6
- Website
- aethl.com/
- Ownership
- Privately Held (backing)
Aethl Bio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Aethl Bio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Aethl Bio in its N-PORT filings yet. We sweep new filings monthly.